Comparison of Efonidipine/Irbesartan combination and Irbesartan monotherapy for uncontrolled hypertension.

Trial Profile

Comparison of Efonidipine/Irbesartan combination and Irbesartan monotherapy for uncontrolled hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Efonidipine (Primary) ; Irbesartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jul 2011 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 07 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top